Business
Certara Scientists are Among the Topmost Cited Biopharma Researchers
Certara celebrates its 200 published papers and 11 scientists on Stanford/Elsevier top 2% cited researchers list in 2025 RADNOR, Pa., Oct. 20, 2025 (GLOBE
About this update from Certara, Inc.
[{"type":"text","content":"Certara celebrates its 200 published papers and 11 scientists on Stanford/Elsevier top 2% cited researchers list in 2025\nRADNOR, Pa., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced its continued influence in pharmaceutical research. With more than 200 papers authored by Certara scientists* this past year and 11 Certara scientists included on the 2025 update of Stanford/Elsevier’s ranking of the top 2% most cited scientists across the globe, Certara’s powerhouse of scientific knowledge continues to drive innovation in drug discovery and development. Certara’s highly ranked experts reflect the company’s commitment to scientific insight and developing technological solutions that further patients’ access to new medicines. Now in its 8th iteration, the list includes the most-cited researchers globally in 22 scientific disciplines and 174 sub-disciplines and encompasses standardized data on citations, h-index, and a wide range of bibliometric indicators. “Rigorous and validated research that accelerates novel medicines drives our teams at Certara,” said William Feehery, CEO at Certara. “I’m proud of our scientists who are leading innovation in the biopharmaceutical industry.” Certara has maintained its leadership in the multidisciplinary field of pharmacology and pharmacokinetics since the inaugural list. This year, the following Certara researchers appeared on Elsevier’s top 2% of the world’s most-cited researchers list either for the single calendar year 2024 or over the span of their entire career: Amin Rostami-Hodjegan, SVP of R&D and Chief Scientific OfficerHannah Jones, SVP, Head of Simcyp PBPK Modeling ServicesHugo Geerts, Head of Neuroscience Modeling, QSPKaren Rowland Yeo, SVP, Client & Regulatory StrategyKhaled Abduljalil, Senior Principal ScientistMasoud Jamei, SVP, Simcyp R&DPatrick F. Smith, SVP, Translational SciencePiet van der Graaf, SVP and Head of Quantitative Systems PharmacologyRajesh Krishna, Senior Distinguished Scientist, Drug Development SolutionsStephen Duffull, Senior Scientific Advisor, Quantitative Science ServicesTrevor Johnson, Principal Scientist Rostami-Hodjegan was also awarded the 2025 Lewis B. Sheiner Lecturer Award by the International Society of Pharmacometrics (ISoP), which recognizes the lifetime achievements o...